Enovis | ENOV - Gross Profit On Sales

Stock Price
32.13
Daily Change
0.58 1.84%
Monthly
24.73%
Yearly
-26.04%
Q3 Forecast
31.86

Enovis reported $334.7M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.



Financials
Stock Price USD
Assets USD 5.02B
Cash and Equivalent USD 38.46M
Cost of Sales USD 282.85M
Current Assets USD 1.28B
Current Liabilities USD 568.18M
Debt USD 1.39B
EBIT USD -16.08M
EBITDA USD 97.2M
Employees 7.37K
EPS Earnings Per Share USD 0.79
Equity Capital and Reserves USD 2.58B
Gross Profit on Sales USD 334.7M
Interest Expense on Debt USD 11.07M
Loan Capital USD 1.37B
Market Capitalization USD 1.8B
Net Income USD -36.74M
Operating Expenses USD 580.63M
Operating Profit USD -16.08M
Ordinary Share Capital USD 57.16M
PE Price to Earnings USD 83.18
Pre-Tax Profit USD -57.35M
Sales Revenues USD 564.5M
Selling and Administration Expenses USD 267.07M
Stock USD 585.91M
Trade Creditors USD 212.02M
Trade Debtors USD 453.7M

Gross Profit On Sales Change Date
Alcidion AUD 15.37M 7.78M Dec/2024
Ambu A/S DKK 887M 55M Jun/2025
Amplifon EUR 147.31M 9.29M Jun/2025
Apollo Hospitals Enterprise Ltd 26.64B 6.6B Mar/2025
Convatec Group 660.5M 348.95M Dec/2024
Diasorin EUR 201M 3M Jun/2025
Enovis USD 334.7M 38.24M Jun/2025
Gulf Medical Proj AED 46.22M 8.48M Mar/2025
Med Life RON 595.95M 109.04M Dec/2024
Oriola-kd EUR 42.3M 300K Jun/2025
Rede D'or Sao Luiz BRL 2.92B 206.03M Jun/2025
Siemens Healthineers EUR 2.18B 142M Jun/2025
Sonova Holding CHF 1.32B 47.7M Sep/2024